PRN: Social Media in Pharma Report 2017: Used to Understand Unmet Needs, Design Clinical Programs & Discover Thought Leaders - Research and Markets

18/mag/2017 11:00:12 PR Newswire Turismo Contatta l'autore

Questo comunicato è stato pubblicato più di 1 anno fa. Le informazioni su questa pagina potrebbero non essere attendibili.

Social Media in Pharma Report 2017: Used to Understand Unmet Needs, Design Clinical Programs & Discover Thought Leaders - Research and Markets


DUBLIN, May 18, 2017 /PRNewswire/ --

Research and Markets has announced the addition of the "Social Media in Pharma" report to their offering.

Research and Markets Logo

Social media covers a range of different online, interactive sites, such as Facebook and Twitter, and these different platforms have a considerable reach and following, with many sites boasting millions of users and daily visits. Despite the rapidly growing popularity of social media, the pharmaceutical industry has been slow to embrace it, constrained by compliance and regulatory concerns and bound by a traditional reluctance for change. However, the successes seen in other industries and the increasing use of social media by key customers - in particular patients and physicians - means that the pharmaceutical industry can no longer afford to ignore social media, and several companies have taken the leap with Facebook pages, Twitter accounts, and a YouTube presence.

Social media is constantly evolving and new sites are regularly emerging; however, it is expected that the longer-standing platforms such as Facebook and Twitter will continue to dominate, particularly in relation to the pharmaceutical industry. As such, most pharmaceutical companies are creating social media teams to both manage their online social media presence and ensure a robust strategy that takes advantage of the range of benefits that social media provides.

Social media gives pharmaceutical companies the opportunity to engage directly with patients and physicians and rapidly respond to questions, requests for information, and negative opinions on products. More advanced companies are utilizing social media to understand unmet needs, design clinical programs, and discover thought leaders. However, there is still a note of caution, with compliance being at the forefront of many pharmaceutical companies' minds, and, while the industry is starting to embrace social media and build on the many opportunities that it affords them, without clear finalized regulatory guidance, remaining compliant will continue to be main challenge facing the industry.

Companies Mentioned

  • Facebook
  • Twitter
  • YouTube

Key Topics Covered:

1. Executive Summary

2. Social Media in the Pharmaceutical Industry

3. How is Social Media Being Used?

4. The Future for Social Media in Pharma

For more information about this report visit

Media Contact:

Laura Wood, Senior Manager 

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716


blog comments powered by Disqus è un servizio offerto da Factotum Srl